Delivery Order SPE2DB20D7061-SPE2DB25FSPQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on August 18, 2025, with a ceiling value of $1,753.78 and firm fixed pricing. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,130.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on September 19, 2025, with a completion date of September 22, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure typical of the agency's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units, with a ceiling value of $2,008.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Risperdal 3 mg tablets in quantities of 60 units, with a ceiling value of $6,678.85 and a firm fixed-price structure. This non-set-aside competitive award is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $2,523.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on September 3, 2025, with completion targeted for September 4, 2025. The contract, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in the same municipality. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- The Defense Logistics Agency awarded a $3,953.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count) on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,373.84 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count units) with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPQ4Delivery Order
The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that establishes the company as a global pharmaceutical prime vendor. Through this comprehensive IDC, AmerisourceBergen supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company serves critical customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a significant vendor within the federal medical supply chain supporting Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 9/10/25 |